Sanctuary Advisors LLC Acquires 1,687 Shares of Astera Labs, Inc. $ALAB

Sanctuary Advisors LLC raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 12.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,843 shares of the company’s stock after purchasing an additional 1,687 shares during the period. Sanctuary Advisors LLC’s holdings in Astera Labs were worth $1,627,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ALAB. Reflection Asset Management purchased a new stake in shares of Astera Labs during the fourth quarter valued at $25,000. Smartleaf Asset Management LLC raised its position in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in Astera Labs during the 4th quarter valued at about $33,000. Wexford Capital LP bought a new position in Astera Labs during the 3rd quarter valued at about $39,000. Finally, National Bank of Canada FI boosted its holdings in shares of Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,676,845 shares of company stock worth $444,928,806 over the last three months. 10.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ALAB. Needham & Company LLC increased their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Barclays raised their price target on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday. Morgan Stanley lifted their price objective on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Finally, Bank of America upped their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $282.00.

Astera Labs Stock Up 3.5%

NASDAQ ALAB opened at $330.89 on Thursday. The stock’s 50-day moving average price is $355.80 and its 200-day moving average price is $224.15. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market capitalization of $56.72 billion, a P/E ratio of 223.57, a price-to-earnings-growth ratio of 3.70 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period in the previous year, the company posted $0.33 EPS. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts anticipate that Astera Labs, Inc. will post 1.86 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.